Reproductive biotechnology has transformed infertility management and animal breeding, with artificial insemination (AI) and in vitro fertilization (IVF) playing pivotal roles. Historically, these technologies have evolved from experimental concepts to essential tools in reproductive medicine and agriculture. AI, introduced in the early 20th century, became instrumental in optimizing breeding programs by allowing selective fertilization without physical mating, thus improving genetic diversity and disease control in livestock. Meanwhile, IVF, developed in the 1970s, marked a milestone in human reproductive health by enabling conception outside the body, providing hope to countless infertile couples. Recent advancements have enhanced these technologies significantly. Precision techniques now allow for more accurate manipulation of gametes and embryos, improving success rates. Cryopreservation has enabled long-term storage of gametes and embryos, facilitating future use and global genetic exchange. Preimplantation genetic testing has emerged as a critical tool for screening embryos for genetic abnormalities, ensuring healthier outcomes. Additionally, artificial intelligence (AI)-[CE1] assisted embryo selection utilizes machine learning to identify embryos with the highest implantation potential, increasing efficiency and success rates. These innovations extend beyond human fertility treatments into animal reproduction, supporting genetic improvement programs and conservation efforts for endangered species. Ethical considerations, however, remain crucial. Issues surrounding genetic manipulation, access to technology, and animal welfare require careful evaluation to ensure responsible use. Looking ahead, the integration of advanced biotechnologies promises further breakthroughs, with potential developments in gene editing and personalized reproductive medicine. Balancing innovation with ethical responsibility will be key to shaping the future of reproductive biotechnology in both human and animal domains.

Keywords: Artificial insemination, in vitro fertilization, animal reproduction, genetic manipulation, preimplantation genetic testing

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.

Reproductive biotechnology has transformed infertility management and animal breeding, with artificial insemination (AI) and in vitro fertilization (IVF) playing pivotal roles. Historically, these technologies have evolved from experimental concepts to essential tools in reproductive medicine and agriculture. AI, introduced in the early 20th century, became instrumental in optimizing breeding programs by allowing selective fertilization without physical mating, thus improving genetic diversity and disease control in livestock. Meanwhile, IVF, developed in the 1970s, marked a milestone in human reproductive health by enabling conception outside the body, providing hope to countless infertile couples. Recent advancements have enhanced these technologies significantly. Precision techniques now allow for more accurate manipulation of gametes and embryos, improving success rates. Cryopreservation has enabled long-term storage of gametes and embryos, facilitating future use and global genetic exchange. Preimplantation genetic testing has emerged as a critical tool for screening embryos for genetic abnormalities, ensuring healthier outcomes. Additionally, artificial intelligence (AI)-[CE1] assisted embryo selection utilizes machine learning to identify embryos with the highest implantation potential, increasing efficiency and success rates. These innovations extend beyond human fertility treatments into animal reproduction, supporting genetic improvement programs and conservation efforts for endangered species. Ethical considerations, however, remain crucial. Issues surrounding genetic manipulation, access to technology, and animal welfare require careful evaluation to ensure responsible use. Looking ahead, the integration of advanced biotechnologies promises further breakthroughs, with potential developments in gene editing and personalized reproductive medicine. Balancing innovation with ethical responsibility will be key to shaping the future of reproductive biotechnology in both human and animal domains.

Keywords: Artificial insemination, in vitro fertilization, animal reproduction, genetic manipulation, preimplantation genetic testing

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.